NO20040738L - A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione. - Google Patents

A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione.

Info

Publication number
NO20040738L
NO20040738L NO20040738A NO20040738A NO20040738L NO 20040738 L NO20040738 L NO 20040738L NO 20040738 A NO20040738 A NO 20040738A NO 20040738 A NO20040738 A NO 20040738A NO 20040738 L NO20040738 L NO 20040738L
Authority
NO
Norway
Prior art keywords
ethoxyl
thiazolidine
dione
pyridyl
benzyl
Prior art date
Application number
NO20040738A
Other languages
Norwegian (no)
Inventor
Jai Patel
Jeffrey Roger Granett
Paul Nigel Wray
Ross Hamish
Robin Price
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Publication of NO20040738L publication Critical patent/NO20040738L/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20040738A 1997-06-05 2004-02-20 A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione. NO20040738L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition
PCT/EP1998/003478 WO1998055122A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
NO20040738L true NO20040738L (en) 2000-02-02

Family

ID=26311662

Family Applications (2)

Application Number Title Priority Date Filing Date
NO995938A NO995938L (en) 1997-06-05 1999-12-03 Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
NO20040738A NO20040738L (en) 1997-06-05 2004-02-20 A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO995938A NO995938L (en) 1997-06-05 1999-12-03 Mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione

Country Status (29)

Country Link
EP (1) EP0998284A1 (en)
JP (1) JP2001521553A (en)
KR (1) KR20010013410A (en)
CN (3) CN1526391A (en)
AP (1) AP1214A (en)
AR (2) AR008198A1 (en)
AU (1) AU8215098A (en)
BG (1) BG104048A (en)
BR (1) BR9810405A (en)
CA (2) CA2333352A1 (en)
CO (1) CO4940400A1 (en)
DZ (1) DZ2510A1 (en)
EA (1) EA002384B1 (en)
GB (1) GB9711683D0 (en)
HU (1) HUP0004070A3 (en)
ID (1) ID24264A (en)
IL (1) IL133074A0 (en)
MX (1) MXPA99011322A (en)
NO (2) NO995938L (en)
NZ (2) NZ523725A (en)
OA (1) OA11306A (en)
PE (1) PE78899A1 (en)
PL (1) PL337201A1 (en)
SK (1) SK164899A3 (en)
TR (2) TR199902963T2 (en)
TW (1) TW570797B (en)
UY (1) UY25032A1 (en)
WO (1) WO1998055122A1 (en)
ZA (2) ZA984826B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246191T1 (en) 1999-04-23 2003-08-15 Smithkline Beecham Plc POLYMORPHOUS OF 5-(4-(2-(N-METHYL-N-(2-PYRDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE MALEIC ACID SALT
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
KR100744359B1 (en) 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 Thiazolidinedione Derivative and its Use as Antidiabetic
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP1854794A1 (en) * 2006-05-09 2007-11-14 Teva Pharmaceutical Industries Ltd. 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
SG47100A1 (en) * 1994-02-10 1998-03-20 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
KR19990036290A (en) * 1995-08-10 1999-05-25 로즈 암스트롱 Reduction of Exogenous Insulin Dosage in Non-insulin-Dependent Diabetic Patients
AU7604596A (en) * 1995-11-17 1997-06-11 Warner-Lambert Company A method of treating myotonic dystrophy
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
AU3552697A (en) * 1996-07-12 1998-02-09 Smithkline Beecham Plc Novel treatment of leptine resistance

Also Published As

Publication number Publication date
NO995938L (en) 2000-02-02
ZA9811572B (en) 1999-07-22
AP9901696A0 (en) 1999-12-31
AU8215098A (en) 1998-12-21
NZ523725A (en) 2004-09-24
TR199902963T2 (en) 2000-02-21
CN1526391A (en) 2004-09-08
CA2292629C (en) 2004-01-06
CN1259050A (en) 2000-07-05
CN1112926C (en) 2003-07-02
PE78899A1 (en) 1999-10-22
EP0998284A1 (en) 2000-05-10
WO1998055122A1 (en) 1998-12-10
AP1214A (en) 2003-10-08
CN1430959A (en) 2003-07-23
GB9711683D0 (en) 1997-08-06
BR9810405A (en) 2000-08-29
SK164899A3 (en) 2000-11-07
CO4940400A1 (en) 2000-07-24
ZA984826B (en) 1999-08-03
JP2001521553A (en) 2001-11-06
OA11306A (en) 2003-10-22
EA002384B1 (en) 2002-04-25
CA2333352A1 (en) 1998-12-10
TR200002790T2 (en) 2001-11-21
ID24264A (en) 2000-07-13
EA199901116A1 (en) 2000-06-26
PL337201A1 (en) 2000-08-14
DZ2510A1 (en) 2003-01-25
BG104048A (en) 2000-07-31
NZ513922A (en) 2001-09-28
KR20010013410A (en) 2001-02-26
MXPA99011322A (en) 2004-12-02
UY25032A1 (en) 1998-11-26
CA2292629A1 (en) 1998-12-10
HUP0004070A2 (en) 2002-02-28
NO995938D0 (en) 1999-12-03
IL133074A0 (en) 2001-03-19
HUP0004070A3 (en) 2002-03-28
AR008198A1 (en) 1999-12-29
AR015120A1 (en) 2001-04-18
TW570797B (en) 2004-01-11

Similar Documents

Publication Publication Date Title
MA24171A1 (en) 5- (2- (4- (1,2-BENZISOTHIAZOLE-3-YL) -1-PIPERAZINYL) ETHYL) -6-CHLORO-1,3-DIHYDRO-2H-INDOLE-2-ONE DIHYDRATES
ID17504A (en) MESILAT TRIHIDRAT 5- (2- (4-1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINIL) -ETYL) -6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ON
FI933804A (en) Monohydrate 5- (2- (4- (1,2-benzisothiazol-3-yl) -1-piperazinyl) ethyl-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride
MX209959B (en) 4- (3-HETEROCICLIL-1-BENZOIL) PIRAZOLES
DK0864582T3 (en) Hypolidemic 1,4-benzothiazepine-1,1-dioxides
NO20040738L (en) A mixture comprising 5- [4- [2- (N-methyl-N-2-pyridyl]) -amino) ethoxyl] benzyl] thiazolidine-2,4-dione.
CY2004003I2 (en) 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PYRINO-9-YL)-METHODY-1,3-PROPANEDIOL DERIVATIVES
DE60004196D1 (en) POLYMORPH OF 5- [4- [2- (N-METHYL-N- (2-PYRDYL) AMINO) ETHOXY] BENZYL] THIAZOLIDIN-2,4-DION, MALEACYL SALT
NO2009002I1 (en) 5- {4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl} thiazolidine-2,4-dionmaleat (salts / solvates) + glimepiride
ID23803A (en) DURUNAN 2- (4-ARIL OR HETEROARIL-PIPERAZIN-1-ILMETIL) -1H-INDOLA
NO20003069D0 (en) 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione-maleic acid salt hydrate as a pharmaceutical
DE59906902D1 (en) HERBICIDES 3- (BENZO (OX / THI) AZOL-7-YL) -1H-PYRIMIDINE-2,4-DIONE
MA25908A1 (en) 5- (4 (2- (N-METHYL-N- (2-PYRIDYL) AMINO)) ETHOXY) BENZYL) THIAZOLIDINE-2,4-DIONE HYDROCHLORIDE
ATE525362T1 (en) 2-(3-(4-(2-T-BUTYL-6-TRIFLUORMETHYLPYRIMIDINE-4-
DE69630123D1 (en) Optische spaltung von 1-azabicylo(2.2.2)octan-3-amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methyl)
IT1313259B1 (en) MACHINE FOR THE ASSEMBLY OF UPPER AND FOOTWEAR OF A FOOTWEAR.
IL160144A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
TR199801735A3 (en) 2- (arylphenyl) amino-imidazoline derivatives.
TR199700296U (en) Harvesting machine.
IT238107Y1 (en) RELIABLE OPERATION RAVIOLI MACHINE
FR2706262B1 (en) Backpack, especially for hiking.
MA25138A1 (en) 5- (2-ETHYL-2H-TATRAZOLE-5-YL) -METHYLE-1,2,3,6- TETRAHYDROPURIDINE
TR199802513A3 (en) N- (4- Carbamimido-phenyl) - phenylglycinamide derivatives.
BR1100223A (en) Derivative of thiazole, e, radicalsuperoxide inhibitor.
ITAT990002U1 (en) "MILLENIUM DUE" PROJECT

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application